Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Schweizerische Medizinische Wochenschrift
|
October 10, 1992
[Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors]
C Zufferey, D Lavanchy, M Reiff, et al.
Alcoholism, Clinical and Experimental Research
|
November 5, 1997
Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis
R Perret, F Froehlich, D Lavanchy, et al.
Journal of Clinical Microbiology
|
September 1, 1994
Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen
D Lavanchy, C Mayerat, B Morel, et al.
The Clinical Investigator
|
November 1, 1993
Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial
J Reichen, M Solioz, H Bühler, et al.
Acta Tropica
|
May 1, 1995
High prevalence of hepatitis C virus among urban and rural population groups in Egypt
A el Gohary, A Hassan, Z Nooman, et al.
Clinical Chemistry
|
September 3, 1999
Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I
H Henry, F Froehlich, R Perret, et al.
Journal of Viral Hepatitis
|
May 1, 2004
Prevention of hepatitis C virus infection
M Kew, G François, D Lavanchy, et al.
Science (New York, N.Y.)
|
September 8, 2001
A global lab against influenza
S P Layne, T J Beugelsdijk, C K Patel, et al.
Journal of Hepatology
|
September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver
J Reichen, L Bianchi, H Bühler, et al.
Occupational and Environmental Medicine
|
June 20, 2008
Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries
D FitzSimons, G François, G De Carli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Schweizerische Medizinische Wochenschrift
|
October 10, 1992
[Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors]
C Zufferey, D Lavanchy, M Reiff, et al.
Alcoholism, Clinical and Experimental Research
|
November 5, 1997
Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis
R Perret, F Froehlich, D Lavanchy, et al.
Journal of Clinical Microbiology
|
September 1, 1994
Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen
D Lavanchy, C Mayerat, B Morel, et al.
The Clinical Investigator
|
November 1, 1993
Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial
J Reichen, M Solioz, H Bühler, et al.
Acta Tropica
|
May 1, 1995
High prevalence of hepatitis C virus among urban and rural population groups in Egypt
A el Gohary, A Hassan, Z Nooman, et al.
Clinical Chemistry
|
September 3, 1999
Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I
H Henry, F Froehlich, R Perret, et al.
Journal of Viral Hepatitis
|
May 1, 2004
Prevention of hepatitis C virus infection
M Kew, G François, D Lavanchy, et al.
Science (New York, N.Y.)
|
September 8, 2001
A global lab against influenza
S P Layne, T J Beugelsdijk, C K Patel, et al.
Journal of Hepatology
|
September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver
J Reichen, L Bianchi, H Bühler, et al.
Occupational and Environmental Medicine
|
June 20, 2008
Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries
D FitzSimons, G François, G De Carli, et al.
Page
of 6